Use of 7T Multimodal Imaging to Detect Brain Changes Associated With Light Therapy in Persons With Mild Cognitive Impairment and Mild Alzheimer's Disease
The study sponsored by the Icahn School of Medicine at Mount Sinai aims to explore the effects of light therapy on sleep, memory, and brain function in patients with Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD). Given the prevalence of sleep disturbances in these populations, which can affect overall health and cognitive function, successful outcomes could lead to the development of innovative light-delivery methods that address these issues. The potential market for cognitive enhancement therapies in aging populations is significant, particularly as the global prevalence of Alzheimer's disease continues to rise. The findings may position the sponsor favorably within the growing field of non-pharmacological interventions for cognitive disorders, although competition from existing and emerging therapies will need to be monitored closely.
Indication: Mild Cognitive Impairment
Modality: medical device
Target: Circadian rhythms and their modulation through light therapy.
Sponsor: Icahn School of Medicine at Mount Sinai
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Circadian rhythms and their modulation through light therapy.
View original source fields
Condition raw: Mild Cognitive Impairment, Alzheimer's Disease
Condition normalized: Mild Cognitive Impairment, Alzheimer's Disease
Modality raw: medical device
Modality normalized: medical device
Target raw: Circadian rhythms and their modulation through light therapy.
Target normalized: Circadian rhythms and their modulation through light therapy.